"Working with a dedicated and experienced clinical trials company that matches your specific needs and trial requirements is critical to guiding every step of your clinical research. With IHS that’s exactly what you’ll receive. We oversee: Study Design and Protocol Development Site and Laboratory Selection Trial Monitoring Sample Collection and Logistics Data Management and Biostatistics"

During the past decade, I.H.S Health LLC conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 1 clinical trials were completed. i.e. 7.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "I.H.S Health LLC" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Landos Biopharma Inc." with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Adiso Therapeutics" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "I.H.S Health LLC" #1 collaborator was "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "I.H.S Health LLC" are "Ulcerative Colitis" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials), "Crohn Disease" (1 trials) and "Crohn's Disease (CD)" (1 trials). Many other conditions were trialed in "I.H.S Health LLC" in a lesser frequency.

Most popular intervention types in "I.H.S Health LLC" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Mirikizumab" (2 trials), "BI 706321" (1 trials), "BT-11 (1000 mg)" (1 trials) and "BT-11 (500 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "I.H.S Health LLC" are 13 trials for "All" genders.

Currently, there are NaN active trials in "I.H.S Health LLC". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in I.H.S Health LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in I.H.S Health LLC, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".